These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25263201)

  • 1. Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice.
    Toya T; Hakuno D; Shiraishi Y; Kujiraoka T; Adachi T
    Physiol Rep; 2014 Sep; 2(9):. PubMed ID: 25263201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
    Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
    Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
    Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
    Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension.
    Bagnost T; Ma L; da Silva RF; Rezakhaniha R; Houdayer C; Stergiopulos N; André C; Guillaume Y; Berthelot A; Demougeot C
    Cardiovasc Res; 2010 Aug; 87(3):569-77. PubMed ID: 20219858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin.
    Bratt JM; Franzi LM; Linderholm AL; O'Roark EM; Kenyon NJ; Last JA
    Toxicol Appl Pharmacol; 2010 Jan; 242(1):1-8. PubMed ID: 19800904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages.
    Tenu JP; Lepoivre M; Moali C; Brollo M; Mansuy D; Boucher JL
    Nitric Oxide; 1999 Dec; 3(6):427-38. PubMed ID: 10637120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.
    Iniesta V; Gómez-Nieto LC; Corraliza I
    J Exp Med; 2001 Mar; 193(6):777-84. PubMed ID: 11257143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.
    Heusch P; Aker S; Boengler K; Deindl E; van de Sand A; Klein K; Rassaf T; Konietzka I; Sewell A; Menazza S; Canton M; Heusch G; Di Lisa F; Schulz R
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H446-53. PubMed ID: 20511413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Neutrophils on Nitric Oxide Production from Stimulated Macrophages.
    Adua E; Danso FO; Boa-Amponsem OM; Adusei-Mensah F
    Iran J Immunol; 2015 Jun; 12(2):94-103. PubMed ID: 26119192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
    Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles.
    Zhang C; Hein TW; Wang W; Miller MW; Fossum TW; McDonald MM; Humphrey JD; Kuo L
    Hypertension; 2004 Dec; 44(6):935-43. PubMed ID: 15492130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.
    Meurs H; Hamer MA; Pethe S; Vadon-Le Goff S; Boucher JL; Zaagsma J
    Br J Pharmacol; 2000 Aug; 130(8):1793-8. PubMed ID: 10952667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase activation through obacunone-dependent arginase inhibition restored impaired endothelial function in ApoE-null mice.
    Yoon J; Park M; Lee Jh; Min BS; Ryoo S
    Vascul Pharmacol; 2014 Mar; 60(3):102-9. PubMed ID: 24509132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
    Sasaki A; Doi S; Mizutani S; Azuma H
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1480-7. PubMed ID: 17322279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase inhibition by piceatannol-3'-O-β-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet.
    Woo A; Shin W; Cuong TD; Min B; Lee JH; Jeon BH; Ryoo S
    Int J Mol Med; 2013 Apr; 31(4):803-10. PubMed ID: 23443634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
    Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
    Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
    Deng J; Wang YW; Chen WM; Wu Q; Huang XN
    Biol Pharm Bull; 2010; 33(4):631-5. PubMed ID: 20410597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries.
    Huynh NN; Harris EE; Chin-Dusting JF; Andrews KL
    Br J Pharmacol; 2009 Jan; 156(1):84-93. PubMed ID: 19133993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increased arginase activity is associated with corpus cavernosum impairment induced by hypercholesterolemia.
    Fraga-Silva RA; Costa-Fraga FP; Faye Y; Sturny M; Santos RA; da Silva RF; Stergiopulos N
    J Sex Med; 2014 May; 11(5):1173-81. PubMed ID: 24612630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.